title: Corneal edema in glaucoma patients after the addition of brinzolamide 1% ophthalmic suspension.
authors.forename: Hisatoshi
authors.initials: H
authors.lastname: Tanimura
authors.forename: Atsushi
authors.initials: A
authors.lastname: Minamoto
authors.forename: Akito
authors.initials: A
authors.lastname: Narai
authors.forename: Tomoko
authors.initials: T
authors.lastname: Hirayama
authors.forename: Mina
authors.initials: M
authors.lastname: Suzuki
authors.forename: Hiromu K
authors.initials: HK
authors.lastname: Mishima
mesh_terms: D000328:Adult; D000368:Aged; D002257:Carbonic Anhydrase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D015715:Corneal Edema / Q000139:chemically induced* / Q000503:physiopathology; D003319:Corneal Stroma / Q000187:drug effects* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D008297:Male; D009883:Ophthalmic Solutions / Q000009:adverse effects; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects*; D013535:Suspensions; D013843:Thiazines / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D002257:Carbonic Anhydrase Inhibitors; D009883:Ophthalmic Solutions; D013449:Sulfonamides; D013535:Suspensions; D013843:Thiazines; C111827:brinzolamide